Shp deletion prevents hepatic steatosis and when combined with Fxr loss protects against type 2 diabetes.

about

Beyond Farnesoid X receptor to target new therapies for NAFLD.Update on FXR Biology: Promising Therapeutic Target?Bile acid signaling and bariatric surgery Idebenone and coenzyme Q10are novel PPARα/γ ligands, with potential for treatment of fatty liver diseases

P2860

Q50196008-8FAC61DD-0F84-4529-937B-EF02A389C9EF Q57114776-D1430E1A-C6BA-4C65-A8AD-E7F9CE842020 Q57124605-EC5AAF33-3340-4B75-9F0D-EC8EAD49F0E0 Q57269164-9C41DA76-E006-49BB-8A8C-8B365D07771F

P2860

Shp deletion prevents hepatic steatosis and when combined with Fxr loss protects against type 2 diabetes.

Item

http://www.wikidata.org/entity/Q38740970

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Shp deletion prevents hepatic ...... tects against type 2 diabetes.

@en

type

Item

label

Shp deletion prevents hepatic ...... tects against type 2 diabetes.

@en

prefLabel

Shp deletion prevents hepatic ...... tects against type 2 diabetes.

@en

P1476

Shp deletion prevents hepatic ...... tects against type 2 diabetes.

@en

P2093

Ann M Zavacki

http://www.w3.org/2001/XMLSchema#string

Jung Eun Park

http://www.w3.org/2001/XMLSchema#string

Lee-Jun Wong

http://www.w3.org/2001/XMLSchema#string

Oludemilade Akinrotimi

http://www.w3.org/2001/XMLSchema#string

Philip VanDuyne

http://www.w3.org/2001/XMLSchema#string

Ryan Riessen

http://www.w3.org/2001/XMLSchema#string

Sayeepriyadarshini Anakk

http://www.w3.org/2001/XMLSchema#string

Yoon Kwang Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects

Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

Farnesoid X receptor is essential for normal glucose homeostasis

Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

Leptin and the regulation of body weight in mammals

Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

Mechanisms for insulin resistance: common threads and missing links

P31

scholarly article

P356

10.1002/HEP.29305

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Kristina Schoonjans

P577

2017-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28586124

http://www.w3.org/2001/XMLSchema#string

P932

5696047

http://www.w3.org/2001/XMLSchema#string

Shp deletion prevents hepatic steatosis and when combined with Fxr loss protects against type 2 diabetes.

about

P2860

P2860

Shp deletion prevents hepatic steatosis and when combined with Fxr loss protects against type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P932